On Monday, the Indian Council of Medical Research published recommendations for the management of Type 1 Diabetes.
“The guidelines come at a time when the COVID19 pandemic has disproportionately affected people with diabetes population, exposing them to a high risk for severe illness and mortality,” informed ICMR in a statement. The guidelines include a vast umbrella of topics including Epidemiology and Diagnosis and Guide for Differential Diagnosis, Drugs -Insulin and Others, monitoring of metabolic control, etc.
The recommendations were conceptualised and compiled by famous researchers and clinicians, including Dr Nikhil Tandon (HOD of Endocrinology & Metabolism, AIIMS, New Delhi), Dr V Mohan (Director, MDRF, Chennai), and Dr R S Dhaliwal (Head, Division of Non-Communicable Diseases, ICMR Hqrs).
The ICMR has produced guidelines for type 1 diabetes for the first time, having previously exclusively released guidelines for type 2 diabetes.
Type 1 diabetes is a chronic illness in which the pancreas generates little or no insulin on its own.
Type 2 diabetes is the most prevalent, generally affecting adults, and arises when the body develops insulin resistance or fails to produce enough insulin. Type 2 diabetes has increased substantially in countries of all income levels during the last three decades.